The invention relates to compounds of the formula I ##STR00001## in which
the radicals have the meanings stated in the text, their stereoisomeric
forms, and their physiologically tolerated salts, physiologically
functional derivatives and process for their preparation.The compounds
are suitable for the treatment of disorders of metabolism, such as type 2
diabetes.